Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subfoveal Choroidal Neovascularization”

56 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 56 results

Large-scale testing (Phase 3)Study completedNCT00470678
What this trial is testing

EXTEND III - Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)

Who this might be right for
Choroidal NeovascularizationAge-Related Macular Degeneration
Novartis 95
Post-approval studies (Phase 4)Study completedNCT04679935
What this trial is testing

Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Novartis Pharmaceuticals 52
Testing effectiveness (Phase 2)Ended earlyNCT00090532
What this trial is testing

The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Pfizer 155
Post-approval studies (Phase 4)Study completedNCT05269966
What this trial is testing

Study to Evaluate the Safety and Effectiveness of Intravitreal Injections (IVI) of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Novartis Pharmaceuticals 105
Large-scale testing (Phase 3)Ended earlyNCT01944839
What this trial is testing

Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy

Who this might be right for
Age-Related Macular Degeneration
Ophthotech Corporation 619
Large-scale testing (Phase 3)Study completedNCT00331864
What this trial is testing

SUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration

Who this might be right for
Age Related Macular DegenerationChoroidal Neovascularization
Novartis 531
Testing effectiveness (Phase 2)Ended earlyNCT01122511
What this trial is testing

Safety and Efficacy of Dexamethasone as Adjunctive Therapy to Ranibizumab in Subjects With Choroidal Neovascularization and Age-Related Macular Degeneration

Who this might be right for
Subfoveal Choroidal NeovascularizationAge-Related Maculopathy
Allergan 4
Large-scale testing (Phase 3)Study completedNCT00150202
What this trial is testing

Clinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration)

Who this might be right for
Macular Degeneration
Pfizer 90
Large-scale testing (Phase 3)Study completedNCT00051129
What this trial is testing

Anecortave Acetate in Subfoveal Choroidal Neovascularization (CNV) Due to Wet Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular DegenerationMaculopathy, Age-RelatedAge-Related Maculopathies+2 more
Alcon Research 291
Large-scale testing (Phase 3)Study completedNCT00090623
What this trial is testing

RhuFab V2 (Ranibizumab) in Subjects With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Genentech, Inc. 180
Testing effectiveness (Phase 2)Study completedNCT00679445
What this trial is testing

Evaluate the Neovista Ophthalmic System for the Treatment of Subfoveal CNV in Patients With AMD That Have Failed Primary Anti-VEGF Therapy

Who this might be right for
Wet Age-related Macular Degeneration
NeoVista 20
Large-scale testing (Phase 3)WithdrawnNCT00930189
What this trial is testing

Comparative Study With Photodynamic Therapy And Triamcinolone Versus Photodynamic Therapy, Triamcinolone And Ranibizumab In Patients With Subfoveal Choroidal Neovascularization

Who this might be right for
Subfoveal Choroidal Neovascularization
Asociación para Evitar la Ceguera en México
Large-scale testing (Phase 3)Ended earlyNCT00139282
What this trial is testing

A Safety and Efficacy Study of Squalamine Lactate for Injection (MSI-1256F) for "Wet" Age-Related Macular Degeneration

Who this might be right for
"Wet" Age-Related Macular Degeneration
Genaera Corporation
Large-scale testing (Phase 3)Ended earlyNCT00433017
What this trial is testing

Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)

Who this might be right for
Macular DegenerationChoroidal Neovascularization
Novartis 255
Early research (Phase 1)Study completedNCT00749021
What this trial is testing

Ranibizumab for Treating Submacular Vascularized Pigment Epithelial Detachments

Who this might be right for
Retinal Pigment Epithelial Detachment
Clement K. Chan 40
Testing effectiveness (Phase 2)UnknownNCT00032396
What this trial is testing

Evaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
Control Delivery Systems
Testing effectiveness (Phase 2)Study completedNCT00239928
What this trial is testing

Clinical Study Of Pegaptanib Sodium (EYE001) For Wet-Type Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
Pfizer 61
Large-scale testing (Phase 3)Study completedNCT00436553
What this trial is testing

Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization

Who this might be right for
Macular DegenerationChoroidal Neovascularization
Novartis 321
Large-scale testing (Phase 3)Study completedNCT00058994
What this trial is testing

An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal CNV Due to Exudative AMD

Who this might be right for
Macular DegenerationMaculopathy, Age-Related
Alcon Research
Large-scale testing (Phase 3)Study completedNCT00429962
What this trial is testing

Study Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNV

Who this might be right for
Choroidal NeovascularizationAge-Related Macular Degeneration
University Hospital, Basel, Switzerland 40
Load More Results